Cadence Bank’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $1.93M | Buy |
5,891
+385
| +7% | +$122K | 0.11% | 123 |
|
|
2025
Q3 | $1.55M | Buy |
5,506
+145
| +3% | +$42.1K | 0.09% | 137 |
|
|
2025
Q2 | $1.5M | Buy |
5,361
+48
| +0.9% | +$13.6K | 0.1% | 142 |
|
|
2025
Q1 | $1.66M | Buy |
5,313
+29
| +0.5% | +$8.56K | 0.12% | 125 |
|
|
2024
Q4 | $1.38M | Sell |
5,284
-219
| -4% | -$65K | 0.09% | 139 |
|
|
2024
Q3 | $1.77M | Sell |
5,503
-223
| -4% | -$72.9K | 0.12% | 122 |
|
|
2024
Q2 | $1.79M | Sell |
5,726
-48
| -0.8% | -$14.1K | 0.13% | 109 |
|
|
2024
Q1 | $1.64M | Buy |
5,774
+684
| +13% | +$200K | 0.12% | 126 |
|
|
2023
Q4 | $1.47M | Sell |
5,090
-393
| -7% | -$107K | 0.12% | 125 |
|
|
2023
Q3 | $1.47M | Sell |
5,483
-33
| -0.6% | -$8.23K | 0.13% | 115 |
|
|
2023
Q2 | $1.22M | Buy |
5,516
+1,282
| +30% | +$297K | 0.11% | 134 |
|
|
2023
Q1 | $1.02M | Sell |
4,234
-3,915
| -48% | -$961K | 0.09% | 146 |
|
|
2022
Q4 | $2.14M | Sell |
8,149
-338
| -4% | -$90.6K | 0.2% | 97 |
|
|
2022
Q3 | $1.91M | Buy |
8,487
+3,618
| +74% | +$877K | 0.2% | 98 |
|
|
2022
Q2 | $1.19M | Sell |
4,869
-225
| -4% | -$55.1K | 0.17% | 72 |
|
|
2022
Q1 | $1.23M | Buy |
5,094
+60
| +1% | +$13.8K | 0.15% | 77 |
|
|
2021
Q4 | $1.13M | Hold |
5,034
| – | – | 0.14% | 89 |
|
|
2021
Q3 | $1.07M | Buy |
5,034
+157
| +3% | +$36.1K | 0.15% | 88 |
|
|
2021
Q2 | $1.19M | Hold |
4,877
| – | – | 0.17% | 80 |
|
|
2021
Q1 | $1.21M | Sell |
4,877
-2,700
| -36% | -$644K | 0.18% | 79 |
|
|
2020
Q4 | $1.74M | Buy |
7,577
+2,700
| +55% | +$623K | 0.27% | 75 |
|
|
2020
Q3 | $1.24M | Sell |
4,877
-60
| -1% | -$14.9K | 0.24% | 75 |
|
|
2020
Q2 | $1.16M | Buy |
4,937
+110
| +2% | +$25.1K | 0.24% | 81 |
|
|
2020
Q1 | $979K | Sell |
4,827
-67
| -1% | -$14.6K | 0.25% | 76 |
|
|
2019
Q4 | $1.18M | Buy |
4,894
+134
| +3% | +$29.5K | 0.22% | 82 |
|
|
2019
Q3 | $921K | Hold |
4,760
| – | – | 0.09% | 97 |
|
|
2019
Q2 | $877K | Sell |
4,760
-65
| -1% | -$11.6K | 0.08% | 96 |
|
|
2019
Q1 | $917K | Hold |
4,825
| – | – | 0.09% | 96 |
|
|
2018
Q4 | $939K | Buy |
4,825
+1
| +0% | +$195 | 0.11% | 94 |
|
|
2018
Q3 | $1M | Sell |
4,824
-81
| -2% | -$16K | 0.09% | 91 |
|
|
2018
Q2 | $905K | Buy |
4,905
+65
| +1% | +$11.5K | 0.08% | 101 |
|
|
2018
Q1 | $825K | Hold |
4,840
| – | – | 0.08% | 105 |
|
|
2017
Q4 | $842K | Buy |
+4,840
| New | +$857K | 0.08% | 103 |
|
Other funds holding AMGN
Cadence Bank's AMGN Position: Q4 2025 in Review
Cadence Bank increased its Amgen (AMGN) stake by 7% in Q4 2025, buying an estimated $122K and bringing the position to 5,891 shares worth $1.93M. The position accounts for 0.11% of the portfolio, ranked #123.
Cadence Bank first reported a position in AMGN in Q4 2017 and has held it in 33 quarters since. The position peaked at $2.14M in Q4 2022. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.
- Cadence Bank held 5,891 shares of Amgen worth $1.93M as of Q4 2025.
- Cadence Bank bought 385 Amgen shares in Q4 2025, an estimated $122K.
- Amgen made up 0.11% of Cadence Bank's portfolio in Q4 2025, its #123 holding.
- Cadence Bank first reported a position in Amgen in Q4 2017 and has held it in 33 quarters since.
- Cadence Bank's Amgen position peaked at $2.14M in Q4 2022.
- 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.
Based on Cadence Bank's 13F filing for Q4 2025, filed 30 Jan 2026.